|
ENY2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.101640E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.259800E-02 |
| Normal-vs-Stage2 |
8.395800E-01 |
| Normal-vs-Stage3 |
4.546200E-01 |
| Normal-vs-Stage4 |
8.802200E-02 |
| Stage1-vs-Stage2 |
2.366000E-01 |
| Stage1-vs-Stage3 |
5.414400E-02 |
| Stage1-vs-Stage4 |
1.112100E-02 |
| Stage2-vs-Stage3 |
6.552400E-01 |
| Stage2-vs-Stage4 |
1.196410E-01 |
| Stage3-vs-Stage4 |
3.189600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.091210E-01 |
| Normal-vs-AfricanAmerican |
2.212400E-01 |
| Normal-vs-Asian |
2.771600E-01 |
| Caucasian-vs-AfricanAmerican |
9.729000E-01 |
| Caucasian-vs-Asian |
2.064600E-01 |
| AfricanAmerican-vs-Asian |
2.104600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.681900E-03 |
| Normal-vs-Female |
3.010200E-01 |
| Male-vs-Female |
1.882650E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.004200E-01 |
| Normal-vs-Extreme_Weight |
6.687700E-02 |
| Normal-vs-Obese |
4.905000E-01 |
| Normal-vs-Extreme_Obese |
1.932170E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.716020E-01 |
| Normal_Weight-vs-Obese |
6.409400E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.011200E-01 |
| Extreme_Weight-vs-Obese |
3.659600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.852400E-01 |
| Obese-vs-Extreme_Obese |
3.498200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.911900E-02 |
| Normal-vs-Age(41-60Yrs) |
1.145780E-01 |
| Normal-vs-Age(61-80Yrs) |
4.714200E-02 |
| Normal-vs-Age(81-100Yrs) |
3.652800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.582180E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.172310E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.591500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.768600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.926200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.576200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.236020E-02 |
| Normal-VS-Type2 PRCC |
6.283400E-01 |
| Normal-VS-KIRP CIMP |
1.034240E-02 |
| Normal-VS-Unclassified PRCC |
5.915600E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.504050E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.57019999996933E-06 |
| Type1 PRCC-VS-Unclassified PRCC |
6.501200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.379000E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.996570E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.969000E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.052600E-01 |
| Normal-vs-N1 |
4.830200E-02 |
| Normal-vs-N2 |
5.956600E-01 |
| N0-vs-N1 |
3.298500E-02 |
| N0-vs-N2 |
3.826200E-01 |
| N1-vs-N2 |
9.020800E-01 |
|
|
